tiprankstipranks
Trending News
More News >
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
US Market

CNBX Pharmaceuticals (CNBX) Income Statement

Compare
121 Followers

CNBX Pharmaceuticals Income Statement

Last quarter (Q2 2025), CNBX Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, CNBX Pharmaceuticals's net income was $-69.79K. See CNBX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 130.07K$ 410.17K$ 29.96K$ 0.00$ 7.16K
Gross Profit
$ 57.75K$ 410.17K$ -169.00K$ -221.00K$ 7.16K
Operating Expenses
$ 713.21K$ 1.34M$ 2.79M$ 2.60M$ 3.05M
Depreciation and Amortization
$ 72.32K$ 162.06K$ 198.53K$ 220.93K$ 215.16K
EBITDA
$ -603.00K$ -3.55M$ -3.52M$ -3.15M$ -7.24M
Operating Income
$ -583.00K$ -931.00K$ -2.95M$ -2.60M$ -3.04M
Other Income/Expenses
$ -112.00K$ -2.78M$ -769.00K$ -594.00K$ -4.42M
Pretax Income
$ -695.00K$ -3.71M$ -3.72M$ -3.19M$ -7.47M
Net Income
$ -695.00K$ -3.71M$ -3.72M$ -3.19M$ -7.47M
Per Share Metrics
Basic EPS
$ -0.02$ -0.42$ -3.59$ -2.16$ -12.00
Diluted EPS
$ -0.02$ -0.42$ -3.59$ -2.16$ -12.00
Weighted Average Shares Outstanding
30.25M 8.82M 1.22M 1.15M 1.12M
Weighted Average Shares Outstanding (Diluted)
30.25M 8.82M 1.22M 1.15M 1.12M
Currency in USD

CNBX Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis